Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Interindividual Variability in the Response to New Oral Direct Anticoagulants (Dabigatran Etexilate, Rivaroxaban or Apixaban) in Patients 80 Years Old and Over, Using a Population Pharmacokinetics Approach.

NCT02464488 is registered in ClinicalTrials.gov with Hôpital Charles Foix as lead sponsor.

NCT NCT02464488
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02464488 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Interindividual Variability in the Response to New Oral Direct Anticoagulants (Dabigatran Etexilate, Rivaroxaban or Apixaban) in Patients 80 Years Old and Over, Using a Population Pharmacokinetics Approach.
Lead sponsor
Hôpital Charles Foix
Phase
Observational
Overall status
Completed
Start date
January 1, 2015
Completion date
August 25, 2021
Enrollment
232 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation